ObsEva (NASDAQ:OBSV) Coverage Initiated by Analysts at StockNews.com

Equities researchers at StockNews.com began coverage on shares of ObsEva (NASDAQ:OBSV) in a research report issued on Wednesday. The firm set a “hold” rating on the stock.

ObsEva Price Performance

ObsEva has a 1-year low of $0.08 and a 1-year high of $2.14. The company has a market cap of $7.94 million, a PE ratio of -0.11 and a beta of 0.68. The company’s 50 day moving average price is $0.01.

About ObsEva

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.